Breaking News
Close
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

Abbott Laboratories (ABT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Abbott Labs's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
113.77 -1.26    -1.10%
20:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
113.75
-0.02
-0.02%
23:33:48 - Real-time Data
  • Volume: 4,925,683
  • Bid/Ask: 113.77 / 114.02
  • Day's Range: 111.83 - 115.16
Type:  Equity
Market:  United States
ISIN:  US0028241000 
CUSIP:  002824100
Abbott Labs 113.77 -1.26 -1.10%
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2022
31/03
2021
31/12
2021
30/09
2021
30/06
Total Current Assets 23429 24239 23492 22627
Cash and Short Term Investments 8158 10249 9692 8944
Cash - - - -
Cash & Equivalents 7675 9799 9302 8658
Short Term Investments 483 450 390 286
Total Receivables, Net 7179 6487 6405 6113
Accounts Receivables - Trade, Net 7179 6487 6405 6113
Total Inventory 5691 5157 5261 5439
Prepaid Expenses 2401 2346 2134 2131
Other Current Assets, Total - - - -
Total Assets 74007 75196 73795 73269
Property/Plant/Equipment, Total - Net 8908 8959 8831 8816
Property/Plant/Equipment, Total - Gross 19521 19364 19182 19074
Accumulated Depreciation, Total -10613 -10405 -10351 -10258
Goodwill, Net 23179 23231 23299 23485
Intangibles, Net 12225 12739 13312 13681
Long Term Investments 763 816 812 805
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 5503 5212 4049 3855
Other Assets, Total - - - -
Total Current Liabilities 12647 13105 12867 12614
Accounts Payable 4757 4408 4017 4017
Payable/Accrued - - - -
Accrued Expenses 6724 6806 6734 6602
Notes Payable/Short Term Debt - - 197 199
Current Port. of LT Debt/Capital Leases 4 754 754 755
Other Current liabilities, Total 1162 1137 1165 1041
Total Liabilities 38608 39394 39373 39469
Total Long Term Debt 17086 17296 17446 17547
Long Term Debt 17086 17296 17446 17547
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest 230 222 216 229
Other Liabilities, Total 8645 8771 8844 9079
Total Equity 35399 35802 34422 33800
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 24304 24470 24285 24153
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) 33295 31528 30376 29053
Treasury Stock - Common -13726 -11822 -10999 -10340
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -8474 -8374 -9240 -9066
Total Liabilities & Shareholders' Equity 74007 75196 73795 73269
Total Common Shares Outstanding 1750.94 1764.08 1768.29 1772.82
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABT Comments

Write your thoughts about Abbott Laboratories
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Babar Ali
Babar Ali Aug 27, 2020 18:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
trump sign 750 million deal with Abbott will go up??
Alexander Nygaard
Alexander Nygaard Aug 27, 2020 18:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
750M deal and the company is valued at 196B... use your brain
Mihai Barbulescu
Mihai Barbulescu Aug 27, 2020 18:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yeah! It will go up a lot! Like 2%!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Our Apps
DOWNLOAD APPApp store
Investing.com
© 2007-2022 Fusion Media Limited. All Rights Reserved.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
  • Sign up for FREE and get:
  • Real-Time Alerts
  • Advanced Portfolio Features
  • Personalized Charts
  • Fully-Synced App
Continue with Google
or
Sign up with Email